PDJ: Hemoglobin A1c Test System

Product code PDJ, “Hemoglobin A1c Test System” in FDA's classification database, is a Class II device type under 21 CFR 862.1373 (hemoglobin A1c test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 27 clearances under PDJ, 27 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
PDJ
Regulation
21 CFR 862.1373
Class
II
Panel
Clinical Chemistry
Clearances
27
Most recent
Oct 2, 2026
Median review, last 2 years
249 days
Third-party review
Not eligible
Implant
No

What it covers

Quantitative determination of Hemoglobin A1c to aid in the diagnosis of diabetes.

FDA’s definition of product code PDJ, from the Product Classification database.

Recent clearances

510(k)DeviceApplicantDecisionType
K260468H100Plus Hemoglobin Testing SystemShenzhen Lifotronic Technology Co., Ltd.Oct 2, 2026Traditional
K252749Medconn 8K Glycated Hemoglobin Test SystemShanghai Medconn Medical Technology Co., Ltd.Jan 6, 2026Traditional
K250073Tosoh Automated Glycohemoglobin Analyzer HLC-723GR01Tosoh Bioscience, Inc.Oct 3, 2025Traditional
K242911Medconn Glycated Hemoglobin Test systemShanghai Medconn Medical Technology Co., Ltd.Jun 20, 2025Traditional
K220999Hipro Glycosylated Hemoglobin (HbA1c) Test SystemShijiazhuang Hipro Biotechnology Co., Ltd.Sep 12, 2024Traditional
K200904Tosoh Automated Glycohemoglobin Analyzer HLC-723G8Tosoh Bioscience, Inc.Aug 5, 2021Traditional
K200256ADVIA Chemistry Enzymatic Hemoglobin Ale (Alc_E) AssaySiemens Healthcare Diagnostics, Inc.Jul 2, 2021Special
K193053Tina-quant Hemoglobin A1cDx Gen.3Roche Diagnostics Operations (Rdo)Mar 26, 2020Traditional
K182651HbA1c AdvancedBeckman Coulter Ireland, Inc.Jan 16, 2019Traditional
K182988Afinion HbA1c Dx on Afinion 2Alere Technologies ASNov 29, 2018Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 27 with a free account)

Clearances by year

27 PDJ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)2181
20252268
20241892
20212501
20201146
20191114
20185203
20173173
20162207
20154234
20142315
20132246

Who submits

16 applicants cleared a PDJ device since 2011. 67% of the clearances went to applicants in United States, then China (15%), Norway (7%) and Canada (4%). By type: Traditional 89%, Special 7% and Post-NSE 4%.

ApplicantClearances since 2011
Bio-Rad Laboratories, Inc.3
Siemens Healthcare Diagnostics, Inc.3
Tosoh Bioscience, Inc.3
Abbott Laboratories2
Alere Technologies AS2
Roche Diagnostics Operations (Rdo)2
Sebia2
Shanghai Medconn Medical Technology Co., Ltd.2

How FDA classifies it

Class II (special controls). The special controls for this device are:

(1) The device must have initial and annual standardization verification by a certifying glycohemoglobin standardization organization deemed acceptable by FDA.

(2) The premarket notification submission must include performance testing to evaluate precision, accuracy, linearity, and interference, including the following:

(i) Performance testing of device precision must, at a minimum, use blood samples with concentrations near 5.0 percent, 6.5 percent, 8.0 percent, and 12 percent hemoglobin A1c. This testing must evaluate precision over a minimum of 20 days using at least three lots of the device and three instruments, as applicable.

(ii) Performance testing of device accuracy must include a minimum of 120 blood samples that span the measuring interval of the device and compare results of the new device to results of a standardized test method. Results must demonstrate little or no bias versus the standardized method.

(iii) Total error of the new device must be evaluated using single measurements by the new device compared to results of the standardized test method, and this evaluation must demonstrate a total error less than or equal to 6 percent.

(iv) Performance testing must demonstrate that there is little to no interference from common hemoglobin variants, including Hemoglobin C, Hemoglobin D, Hemoglobin E, Hemoglobin A2, and Hemoglobin S.

(3) When assay interference from Hemoglobin F or interference with other hemoglobin variants with low frequency in the population is observed, a warning statement must be placed in a black box and must appear in all labeling material for these devices describing the interference and any affected populations.

From 21 CFR 862.1373. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 862.1373 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent PDJ clearances declared.

Ask about PDJ

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about PDJ

What is FDA product code PDJ?

Product code PDJ, “Hemoglobin A1c Test System” in FDA's classification database, is a Class II device type under 21 CFR 862.1373 (hemoglobin A1c test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 27 clearances under PDJ, 27 of them since 2011.

How many 510(k) clearances are there under PDJ?

FDA’s 510(k) database listed 27 clearances under PDJ as of Oct 29, 2026, 27 of them decided since 2011; the most recent decision was Oct 2, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a PDJ 510(k)?

For the 4 PDJ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 249 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most PDJ clearances?

Since 2011: Bio-Rad Laboratories, Inc. (3), Siemens Healthcare Diagnostics, Inc. (3), Tosoh Bioscience, Inc. (3), Abbott Laboratories (2) and Alere Technologies AS (2). 16 applicants have cleared a PDJ device in that time.

Sources

  1. FDA product classification: PDJ · Product Classification database
  2. 21 CFR 862.1373: Hemoglobin A1c test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for PDJ · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow PDJGet an email when FDA clears, recalls or publishes guidance for PDJ devices.

Know what FDA already cleared.